• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Emergent, J&J settle COVID vaccine supply deal dispute

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 08, 2024 at 11:12: PM
via Emergent BioSolutions (EBS.N) said on Monday Johnson & Johnson (JNJ.N) has agreed to pay $50 million to settle claims related to a terminated manufacturing deal for the latter's COVID-19 vaccine.

article source
 

<



Similar threads

cafead
Johnson &amp; Johnson isn&#039;t finished with Emergent dispute, files arbitration demand
Replies
0
Views
113
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J, Emergent Accuse Each Other Of Violating COVID-19 Vaccine Deal
Replies
0
Views
289
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Emergent wins FDA all-clear to restart J&amp;J COVID-19 vaccine production in Baltimore
Replies
0
Views
219
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA authorizes more J&amp;J vaccines made at Emergent plant
Replies
0
Views
198
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses
Replies
0
Views
146
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote